ACTA1 and acute lymphoblastic leukemia: The analysis of the expression of several markers differentially expressed by M1- and M2-like MØs [30] showed that ALL-derived CM caused a notable reduction (~50%) in the expression of the M1 marker Activin A (ActA) (Figure 3C).